32176-33-3 Usage
General Description
1-[(4-ethoxyphenyl)sulfonyl]piperidine is a chemical compound with the molecular formula C15H23NO3S. It is a piperidine derivative containing a sulfonyl group and an ethoxyphenyl group. 1-[(4-ethoxyphenyl)sulfonyl]piperidine is frequently used in organic chemistry as a reagent for various synthesis reactions. It has been found to possess potential pharmacological properties and is being researched for its potential use in medicinal and pharmaceutical applications. Due to its structural features, it may have the ability to interact with specific biological targets and is under investigation for its possible therapeutic effects.
Check Digit Verification of cas no
The CAS Registry Mumber 32176-33-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,1,7 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 32176-33:
(7*3)+(6*2)+(5*1)+(4*7)+(3*6)+(2*3)+(1*3)=93
93 % 10 = 3
So 32176-33-3 is a valid CAS Registry Number.
32176-33-3Relevant academic research and scientific papers
Ionic liquid enabled sulfamoylation of arenes: An ambient, expeditious and regioselective protocol for aryl sulfonamides
Naik, Prashant U.,Harjani, Jitendra R.,Nara, Susheel J.,Salunkhe, Manikrao M.
, p. 1933 - 1936 (2007/10/03)
The ionic liquid, 1-butyl-3-methylimidazolium chloroaluminate, [bmim]Cl·AlCl3, N=0.67 mediated syntheses of aromatic sulfonamides via electrophilic substitution of arenes is reported. The protocol serves as a distinctly expeditious and ambient route towards the syntheses of these pharmaceutically useful compounds, yielding quantitative conversions at room temperature within 5-30min in most of the cases. The Lewis acidity and molar stoichiometry of the ionic liquid influences the extent of conversion. The method has been used for the syntheses of a diverse range of sulfonamides by variation of arenes and sulfamoyl chlorides. With monosubstituted benzenes, the protocol offers an added advantage of exclusive selectivity towards the formation of para substituted sulfonamides over the ortho products.
